Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Oliver IlliniDepartment of Respiratory and Critical Care Medicine, Clinic Floridsdorf, Vienna Healthcare Group, 1130 Vienna, Austria.ORCID 0000-0002-7322-7092
Michal BenejDepartment of Thoracic Surgery, Clinic Floridsdorf, Vienna Healthcare Group, 1210 Vienna, Austria.ORCID 0009-0003-6330-1951
Anna Sophie Lang-StöberlKarl Landsteiner Institute of Lung Research and Pulmonary Oncology, Clinic Floridsdorf, 1210 Vienna, Austria.ORCID 0009-0005-3204-8943
Hannah FabikanKarl Landsteiner Institute of Lung Research and Pulmonary Oncology, Clinic Floridsdorf, 1210 Vienna, Austria.
Luka BrcicDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-9098-8416
Florian SucherDiagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
Tibor KrajcDepartment of Thoracic Surgery, Clinic Floridsdorf, Vienna Healthcare Group, 1210 Vienna, Austria.
Christoph WeinlingerKarl Landsteiner Institute of Lung Research and Pulmonary Oncology, Clinic Floridsdorf, 1210 Vienna, Austria.
Maximilian J HochmairDepartment of Respiratory and Critical Care Medicine, Clinic Floridsdorf, Vienna Healthcare Group, 1130 Vienna, Austria.ORCID 0000-0002-8673-2450
Arschang ValipourDepartment of Respiratory and Critical Care Medicine, Clinic Floridsdorf, Vienna Healthcare Group, 1130 Vienna, Austria.
Thomas KlikovitsDepartment of Thoracic Surgery, Clinic Floridsdorf, Vienna Healthcare Group, 1210 Vienna, Austria.
Stefan WatzkaDepartment of Thoracic Surgery, Clinic Floridsdorf, Vienna Healthcare Group, 1210 Vienna, Austria.ORCID 0000-0002-4149-4890
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Prognostic Value of PD-L1, BAP-1 and ILK in Pleural Mesothelioma. · full record | OpenQuestion